By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today reported that its fourth-quarter molecular diagnostics sales increased 21 percent year over year.

Abbott's total diagnostics sales were $1.02 billion for the quarter, up 4 percent year over year.

Its molecular diagnostics sales contributed $114 million to that total and were up 21 percent. Its US molecular diagnostics sales were $55 million, up 32 percent, and its international sales were up roughly 13 percent at $59 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.